Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Rankning i aktier #26679
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Aktiekurs
$3.49
Senast synkroniserad: 2023-12-19
Marknadsvärde
$38.68M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Neoleukin Therapeutics, Inc. (NLTX)

Kategori

Aktiekurshistorik för Neoleukin Therapeutics, Inc. (NLTX)
Högsta slutkurs: $3.45 den 2023-12-01

Lägsta slutkurs: $64.26 den 2014-03-01
Aktiekurshistorik för Neoleukin Therapeutics, Inc. från 2014 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$163.10 25.36%
DE
$38.00 22.72%
JP
$220.90 33.43%
CH
$21.01 11.96%
IN